• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Pharma Sales Ops - General Discussion

Replies
0
Views
716
anonymous
Replies
22
Views
15K
anonymous
Replies
0
Views
809
anonymous
Replies
0
Views
1K
anonymous
Replies
11
Views
6K
anonymous
Replies
1
Views
3K
anonymous
Replies
0
Views
2K
anonymous
Replies
1
Views
2K
Tom McGee
Replies
0
Views
2K
anonymous